ey0019.9-3 | Metabolic risk in childhood cancer | ESPEYB19
S Welsch
, K Sawadogo
, B Brichard
, Ville de Goyet M de
, Damme A Van
, C Boulanger
, P Lysy
sophie.welsch@uclouvain.be Diabet Med. 2022; 39: e14720. PMID: 34652870.Brief Summary: Childhood cancer survivors are at increased risk of hyperglycaemia and diabetes due to cancer treatments as asparaginase, steroids and total body irradiation. This single center, retrospective study analyzed the prevalence of hyperglycaemia in 267 patients treated between 2004 and 2019 for hematologic malignancie...